Lawrence Kenyon – Biography
Last update: April 7, 2026Executive profile
Lawrence was Chief Operating Officer and Chief Financial Officer at Arno Therapeutics, and President, Chief Executive Officer and Chief Financial Officer at Tamir Biotechnology. Lawrence Kenyon joined Outlook Therapeutics in 2024. Lawrence served as Chief Financial Officer and Interim Chief Executive Officer and Chief Financial Officer for Outlook Therapeutics.
Lawrence Kenyon is currentlyChief Financial Officer and Director at Outlook Therapeutics - View - Outlook Therapeutics org chart
Create your alert
to follow the career of Lawrence Kenyon.
Education
Lawrence Kenyon has a Bachelor of Business Administration in Accounting from University of Wisconsin-Whitewater.
They have also studied at University of Wisconsin-Whitewater :
Find more alumni from University of Wisconsin-Whitewater
More about Lawrence Kenyon
Selected links
Do you need to know more about Lawrence Kenyon? More results.
Participate
Social media
- Lawrence Kenyon on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Lawrence Kenyon
The colleagues of Lawrence Kenyon
Company Colleagues
- At Outlook Therapeutics, Lawrence Kenyon has 26 colleagues including Bob Jahr (CEO), Randy Thurman (Director)…
Industry Colleagues
- In the Biotechnology industry, Lawrence Kenyon has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Lawrence Kenyon.
Get in Touch
Here are a few tips for establishing great contacts.
